PURPOSE: The surgical treatment of congenital anomalies using tissues engineered from
amniotic fluid-derived mesenchymal cells has been validated experimentally. As a …

Purpose: This study was aimed at determining whether fetal tissue constructs can be
engineered from cells normally found in the amniotic fluid. Methods: A subpopulation of …

PURPOSE: Because of the 4 to 6-month interval between a diagnostic amniocentesis and
birth, clinical application of amniotic mesenchymal stem cell (AMSC)-based therapies …

BACKGROUND: We have recently shown, in an animal model, that amniotic fluid can be a
source of cells for fetal tissue engineering. This study was aimed at determining whether …

Abstract Background Mesenchymal stromal cells (MSCs) are currently being evaluated in
numerous pre-clinical and clinical cell-based therapy studies. Furthermore, there is an …

Over the past decade, amniotic fluid-derived stem cells have emerged as a novel,
experimental approach for the treatment of a wide variety of congenital anomalies …

ABSTRACT Introduction Stem cells (SCs) isolated from amniotic fluid (AF) are a promising
source for autologous perinatal cell therapy. The aim of this study was to develop a routine …

Purpose: This study was aimed at determining whether fetal tissue constructs can be
engineered from cells derived from the placenta. Methods: A subpopulation of …

We determined whether cartilage could be engineered from mesenchymal progenitor cells
(MPCs) normally found in amniotic fluid. Mesenchymal amniocytes were isolated from ovine …

Stem cells isolated from amniotic fluid are known to be able to differentiate into different cells
types, thus being considered as a powerful tool for cellular therapy of different human …